Genmab — April 2018
-
short robotterne har det let... ikke megen købelyst
-
Selv om kombien ikke havde særlig effekt i MM i dette studie https://www.clinicaltrials.gov/ct2/show/NCT03000452?term=daratumumab+durvalumab&rank=1
-
Det kunne skabe noget shortpanik hvis Genmab opkøbte egne aktier som Florian snakker om og shorterne samtidig ville lukke sine short aktier . Drømmesenarie
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind


